Bivatuzumab
Bivatuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Bivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6.
Trade Name | Bivatuzumab |
Generic | Bivatuzumab |
Bivatuzumab Other Names | Bivatuzumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in cancer/tumors (unspecified) and head and neck cancer.
Innovators Monograph
You find simplified version here Bivatuzumab